DENTSPLY SIRONA Statistics
Total Valuation
XRAY has a market cap or net worth of $5.47 billion. The enterprise value is $7.39 billion.
| Market Cap | 5.47B |
| Enterprise Value | 7.39B |
Important Dates
The next confirmed earnings date is Wednesday, July 31, 2024, before market open.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
XRAY has 207.63 million shares outstanding. The number of shares has decreased by -2.80% in one year.
| Shares Outstanding | 207.63M |
| Shares Change (YoY) | -2.80% |
| Shares Change (QoQ) | -0.67% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 103.33% |
| Float | 206.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.14 |
| PS Ratio | 1.39 |
| Forward PS | 1.35 |
| PB Ratio | 1.68 |
| P/FCF Ratio | 19.14 |
| PEG Ratio | 1.53 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.16, with an EV/FCF ratio of 25.85.
| EV / Earnings | n/a |
| EV / Sales | 1.88 |
| EV / EBITDA | 24.16 |
| EV / EBIT | n/a |
| EV / FCF | 25.85 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.43 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 7.22 |
| Debt / FCF | 7.73 |
| Interest Coverage | -0.49 |
Financial Efficiency
Return on equity (ROE) is -2.80% and return on invested capital (ROIC) is -0.75%.
| Return on Equity (ROE) | -2.80% |
| Return on Assets (ROA) | -1.30% |
| Return on Capital (ROIC) | -0.75% |
| Revenue Per Employee | $262,667 |
| Profits Per Employee | -$6,333 |
| Employee Count | 15,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.94 |
Taxes
| Income Tax | -24.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.19% in the last 52 weeks. The beta is 1.02, so XRAY's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -35.19% |
| 50-Day Moving Average | 26.63 |
| 200-Day Moving Average | 31.06 |
| Relative Strength Index (RSI) | 53.38 |
| Average Volume (20 Days) | 2,814,828 |
Short Selling Information
The latest short interest is 13.30 million, so 6.41% of the outstanding shares have been sold short.
| Short Interest | 13.30M |
| Short Previous Month | 12.94M |
| Short % of Shares Out | 6.41% |
| Short % of Float | 6.45% |
| Short Ratio (days to cover) | 4.98 |
Income Statement
In the last 12 months, XRAY had revenue of $3.94 billion and -$95.00 million in losses. Loss per share was -$0.44.
| Revenue | 3.94B |
| Gross Profit | 2.07B |
| Operating Income | -41.00M |
| Pretax Income | -119.00M |
| Net Income | -95.00M |
| EBITDA | 306.00M |
| EBIT | -39.00M |
| Loss Per Share | -$0.44 |
Balance Sheet
The company has $291.00 million in cash and $2.21 billion in debt, giving a net cash position of -$1.92 billion or -$9.24 per share.
| Cash & Cash Equivalents | 291.00M |
| Total Debt | 2.21B |
| Net Cash | -1.92B |
| Net Cash Per Share | -$9.24 |
| Equity (Book Value) | 3.26B |
| Book Value Per Share | 15.69 |
| Working Capital | 572.00M |
Cash Flow
In the last 12 months, operating cash flow was $423.00 million and capital expenditures -$137.00 million, giving a free cash flow of $286.00 million.
| Operating Cash Flow | 423.00M |
| Capital Expenditures | -137.00M |
| Free Cash Flow | 286.00M |
| FCF Per Share | $1.38 |
Margins
Gross margin is 52.61%, with operating and profit margins of -1.04% and -2.41%.
| Gross Margin | 52.61% |
| Operating Margin | -1.04% |
| Pretax Margin | -3.02% |
| Profit Margin | -2.41% |
| EBITDA Margin | 7.77% |
| EBIT Margin | -0.99% |
| FCF Margin | 7.26% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 2.43%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 2.43% |
| Dividend Growth (YoY) | 13.21% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | 2.80% |
| Shareholder Yield | 5.23% |
| Earnings Yield | -1.74% |
| FCF Yield | 5.23% |
Analyst Forecast
The average price target for XRAY is $33.67, which is 27.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $33.67 |
| Price Target Difference | 27.73% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 4.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 18, 2006. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 18, 2006 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
XRAY has an Altman Z-Score of 1.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.52 |
| Piotroski F-Score | 6 |